Alliance in seeks to develop fluid-based accommodating IOLs

PowerVision has developed an accommodating IOL which has donstrated in pilot studies the ability to change focus via a fluid-driven shape-changing technology. The accommodating IOL is intended for cataract patients who also have presbyopia.The technology utilises the eye’s natural accommodating muscles to transport fluid in the intraocular lens, which is implanted in the eye’s capsular bag. We are committed to finding and developing the best, most innovative treatment option for cataract patients who live with presbyopia, Mr Michael Onuscheck, global surgical franchise head at Alcon, said. The fluid-based technology that PowerVision is working on represents a potential game-changer in the category with the promise to offer patients a natural, continuous range of near to far vision. We are excited about our new alliance with Alcon, and look forward to working together to bring this exciting technology to market, Mr Barry Cheskin, president, CEO and co-founder of PowerVision, said.Currently, most intraocular lenses, which are used to treat presbyopia, are multifocal IOLs which work by distributing light between different focal points allowing patients to see at multiple distances. Accommodating IOLs utilise the natural contraction of the eye’s muscle to actively focus on close objects, providing patients with a continuous range of vision.Alcon’s investment in PowerVision will fund further development and clinical trials, and provide Alcon the option to acquire the company.